Repetitive Transcranial Magnetic Stimulation (rTMS) for depression

outcomes in a United Kingdom (UK) clinical practice

Chris Griffiths, Alex O'Neill-Kerr, Timothy Millward, Ksenija Da Silva

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Objective:
The aim of this paper is to present the outcomes data from the largest United Kingdom’s (UK) National Health Service (NHS) clinical rTMS service treating treatment resistant depression (TRD).

Methods:
The study was a retrospective investigation of routinely collected data on patients receiving rTMS between 2015 and 2017. Measures used were the clinician-rated Clinical Global Impression (CGI) and Hamilton Depression Rating Scale (HAM-D), and patient rated Beck Depression Inventory (BDI). The outcome data of 73 patients with TRD was analysed. The sample included patients with co-morbid psychiatric diagnosis.

Results:
Response and remission rates respectively were 40.4% and 25.5% for the HAM-D; 35.6% and 20.8% for the BDI; and 51.1% and 52.1% for the CGI. Effect sizes were medium (.54, .52 and .56 respectively).

Conclusions:
The results show that a UK based clinical service achieves similar results to those published internationally and that clinical rTMS can have significant impact on symptoms of depression in many patients with TRD. Health services are under pressure to make financial savings, investment in rTMS could reduce the long term treatment costs associated with TRD.
Original languageEnglish
Pages (from-to)122-127
Number of pages6
JournalInternational Journal of Psychiatry in Clinical Practice
Volume23
Issue number2
Early online date30 Mar 2019
DOIs
Publication statusE-pub ahead of print - 30 Mar 2019

Fingerprint

Transcranial Magnetic Stimulation
Treatment-Resistant Depressive Disorder
Depression
Equipment and Supplies
National Health Programs
Mental Disorders
Health Care Costs
Health Services
United Kingdom
Pressure

Keywords

  • Repetitive Transcranial Magnetic Stimulation (rTMS)
  • naturalistic
  • service delivery
  • treatment-resistant depression

Cite this

@article{af14b4f5f5a54882bf85807d7717ccff,
title = "Repetitive Transcranial Magnetic Stimulation (rTMS) for depression: outcomes in a United Kingdom (UK) clinical practice",
abstract = "Objective:The aim of this paper is to present the outcomes data from the largest United Kingdom’s (UK) National Health Service (NHS) clinical rTMS service treating treatment resistant depression (TRD).Methods:The study was a retrospective investigation of routinely collected data on patients receiving rTMS between 2015 and 2017. Measures used were the clinician-rated Clinical Global Impression (CGI) and Hamilton Depression Rating Scale (HAM-D), and patient rated Beck Depression Inventory (BDI). The outcome data of 73 patients with TRD was analysed. The sample included patients with co-morbid psychiatric diagnosis.Results:Response and remission rates respectively were 40.4{\%} and 25.5{\%} for the HAM-D; 35.6{\%} and 20.8{\%} for the BDI; and 51.1{\%} and 52.1{\%} for the CGI. Effect sizes were medium (.54, .52 and .56 respectively).Conclusions:The results show that a UK based clinical service achieves similar results to those published internationally and that clinical rTMS can have significant impact on symptoms of depression in many patients with TRD. Health services are under pressure to make financial savings, investment in rTMS could reduce the long term treatment costs associated with TRD.",
keywords = "Repetitive Transcranial Magnetic Stimulation (rTMS), naturalistic, service delivery, treatment-resistant depression",
author = "Chris Griffiths and Alex O'Neill-Kerr and Timothy Millward and {Da Silva}, Ksenija",
year = "2019",
month = "3",
day = "30",
doi = "10.1080/13651501.2018.1562077",
language = "English",
volume = "23",
pages = "122--127",
journal = "International Journal of Psychiatry in Clinical Practice",
number = "2",

}

Repetitive Transcranial Magnetic Stimulation (rTMS) for depression : outcomes in a United Kingdom (UK) clinical practice. / Griffiths, Chris; O'Neill-Kerr, Alex; Millward, Timothy; Da Silva, Ksenija.

In: International Journal of Psychiatry in Clinical Practice, Vol. 23, No. 2, 30.03.2019, p. 122-127.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Repetitive Transcranial Magnetic Stimulation (rTMS) for depression

T2 - outcomes in a United Kingdom (UK) clinical practice

AU - Griffiths, Chris

AU - O'Neill-Kerr, Alex

AU - Millward, Timothy

AU - Da Silva, Ksenija

PY - 2019/3/30

Y1 - 2019/3/30

N2 - Objective:The aim of this paper is to present the outcomes data from the largest United Kingdom’s (UK) National Health Service (NHS) clinical rTMS service treating treatment resistant depression (TRD).Methods:The study was a retrospective investigation of routinely collected data on patients receiving rTMS between 2015 and 2017. Measures used were the clinician-rated Clinical Global Impression (CGI) and Hamilton Depression Rating Scale (HAM-D), and patient rated Beck Depression Inventory (BDI). The outcome data of 73 patients with TRD was analysed. The sample included patients with co-morbid psychiatric diagnosis.Results:Response and remission rates respectively were 40.4% and 25.5% for the HAM-D; 35.6% and 20.8% for the BDI; and 51.1% and 52.1% for the CGI. Effect sizes were medium (.54, .52 and .56 respectively).Conclusions:The results show that a UK based clinical service achieves similar results to those published internationally and that clinical rTMS can have significant impact on symptoms of depression in many patients with TRD. Health services are under pressure to make financial savings, investment in rTMS could reduce the long term treatment costs associated with TRD.

AB - Objective:The aim of this paper is to present the outcomes data from the largest United Kingdom’s (UK) National Health Service (NHS) clinical rTMS service treating treatment resistant depression (TRD).Methods:The study was a retrospective investigation of routinely collected data on patients receiving rTMS between 2015 and 2017. Measures used were the clinician-rated Clinical Global Impression (CGI) and Hamilton Depression Rating Scale (HAM-D), and patient rated Beck Depression Inventory (BDI). The outcome data of 73 patients with TRD was analysed. The sample included patients with co-morbid psychiatric diagnosis.Results:Response and remission rates respectively were 40.4% and 25.5% for the HAM-D; 35.6% and 20.8% for the BDI; and 51.1% and 52.1% for the CGI. Effect sizes were medium (.54, .52 and .56 respectively).Conclusions:The results show that a UK based clinical service achieves similar results to those published internationally and that clinical rTMS can have significant impact on symptoms of depression in many patients with TRD. Health services are under pressure to make financial savings, investment in rTMS could reduce the long term treatment costs associated with TRD.

KW - Repetitive Transcranial Magnetic Stimulation (rTMS)

KW - naturalistic

KW - service delivery

KW - treatment-resistant depression

UR - https://pure.northampton.ac.uk/en/publications/af14b4f5-f5a5-4882-bf85-807d7717ccff

U2 - 10.1080/13651501.2018.1562077

DO - 10.1080/13651501.2018.1562077

M3 - Article

VL - 23

SP - 122

EP - 127

JO - International Journal of Psychiatry in Clinical Practice

JF - International Journal of Psychiatry in Clinical Practice

IS - 2

ER -